Literature DB >> 24488096

The granzyme B-Serpinb9 axis controls the fate of lymphocytes after lysosomal stress.

C H Bird1, M E Christensen2, M S J Mangan1, M D Prakash1, K A Sedelies3, M J Smyth3, I Harper4, N J Waterhouse2, P I Bird1.   

Abstract

Cytotoxic lymphocytes (CLs) contain lysosome-related organelles (LROs) that perform the normal degradative functions of the lysosome, in addition to storage and release of powerful cytotoxins employed to kill virally infected or abnormal cells. Among these cytotoxins is granzyme B (GrB), a protease that has also been implicated in activation (restimulation)-induced cell death of natural killer (NK) and T cells, but the underlying mechanism and its regulation are unclear. Here we show that restimulation of previously activated human or mouse lymphocytes induces lysosomal membrane permeabilisation (LMP), followed by GrB release from LROs into the CL cytosol. The model lysosomal stressors sphingosine and Leu-Leu-methyl-ester, and CLs from gene-targeted mice were used to show that LMP releases GrB in both a time- and concentration-dependent manner, and that the liberated GrB is responsible for cell death. The endogenous GrB inhibitor Serpinb9 (Sb9) protects CLs against LMP-induced death but is decreasingly effective as the extent of LMP increases. We also used these model stressors to show that GrB is the major effector of LMP-mediated death in T cells, but that in NK cells additional effectors are released, making GrB redundant. We found that limited LMP and GrB release occurs constitutively in proliferating lymphocytes and in NK cells engaged with targets in vitro. In Ectromelia virus-infected lymph nodes, working NK cells lacking Sb9 are more susceptible to GrB-mediated death. Taken together, these data show that a basal level of LMP occurs in proliferating and activated lymphocytes, and is increased on restimulation. LMP releases GrB from LROs into the lymphocyte cytoplasm and its ensuing interaction with Sb9 dictates whether or not the cell survives. The GrB-Sb9 nexus may therefore represent an additional mechanism of limiting lymphocyte lifespan and populations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24488096      PMCID: PMC4013521          DOI: 10.1038/cdd.2014.7

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  52 in total

1.  Suicide induced by cytolytic activity controls the differentiation of memory CD8(+) T lymphocytes.

Authors:  J T Opferman; B T Ober; R Narayanan; P G Ashton-Rickardt
Journal:  Int Immunol       Date:  2001-04       Impact factor: 4.823

2.  Target cell-induced apoptosis of interleukin-2-activated human natural killer cells: roles of cell surface molecules and intracellular events.

Authors:  A Yamauchi; K Taga; H S Mostowski; E T Bloom
Journal:  Blood       Date:  1996-06-15       Impact factor: 22.113

3.  Target-induced natural killer cell loss as a measure of NK cell responses.

Authors:  Hilary S Warren
Journal:  J Immunol Methods       Date:  2011-06-15       Impact factor: 2.303

4.  Monoclonal antibodies detecting discrete epitopes of human perforin.

Authors:  M Geisberg; J A Trapani; B Dupont
Journal:  Tissue Antigens       Date:  1990-05

5.  Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells.

Authors:  Satish Devadas; Jyoti Das; Catherine Liu; Liying Zhang; Arthur I Roberts; Zui Pan; Paul A Moore; Gobardhan Das; Yufang Shi
Journal:  Immunity       Date:  2006-08-10       Impact factor: 31.745

Review 6.  The many roles of FAS receptor signaling in the immune system.

Authors:  Andreas Strasser; Philipp J Jost; Shigekazu Nagata
Journal:  Immunity       Date:  2009-02-20       Impact factor: 31.745

7.  Caspase-cleaved HPK1 induces CD95L-independent activation-induced cell death in T and B lymphocytes.

Authors:  Dirk Brenner; Alexander Golks; Mareike Becker; Wolfgang Müller; Christian R Frey; Rostislav Novak; Doron Melamed; Friedemann Kiefer; Peter H Krammer; Rüdiger Arnold
Journal:  Blood       Date:  2007-08-21       Impact factor: 22.113

8.  Serine protease inhibitor 6-deficient mice have increased neutrophil immunity to Pseudomonas aeruginosa.

Authors:  Manling Zhang; Ni Liu; Sun-Mi Park; Yue Wang; Susan Byrne; Andrea E Murmann; Scott Bahr; Marcus E Peter; Steven T Olson; Abderrazzaq Belaaouaj; Philip G Ashton-Rickardt
Journal:  J Immunol       Date:  2007-10-01       Impact factor: 5.422

9.  The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency.

Authors:  Claire E Hirst; Marguerite S Buzza; Catherina H Bird; Hilary S Warren; Paul U Cameron; Manling Zhang; Philip G Ashton-Rickardt; Phillip I Bird
Journal:  J Immunol       Date:  2003-01-15       Impact factor: 5.422

10.  Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway.

Authors:  C H Bird; V R Sutton; J Sun; C E Hirst; A Novak; S Kumar; J A Trapani; P I Bird
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

View more
  17 in total

1.  Noninvasive optical detection of granzyme B from natural killer cells with enzyme-activated fluorogenic probes.

Authors:  Tomasz Janiszewski; Sonia Kołt; Dion Kaiserman; Scott J Snipas; Shuang Li; Julita Kulbacka; Jolanta Saczko; Niels Bovenschen; Guy Salvesen; Marcin Drąg; Phillip I Bird; Paulina Kasperkiewicz
Journal:  J Biol Chem       Date:  2020-05-21       Impact factor: 5.157

2.  Cathepsin G Inhibition by Serpinb1 and Serpinb6 Prevents Programmed Necrosis in Neutrophils and Monocytes and Reduces GSDMD-Driven Inflammation.

Authors:  Sabrina Sofia Burgener; Nathan Georges François Leborgne; Scott J Snipas; Guy S Salvesen; Phillip Ian Bird; Charaf Benarafa
Journal:  Cell Rep       Date:  2019-06-18       Impact factor: 9.423

3.  Transcriptomics of Acute DENV-Specific CD8+ T Cells Does Not Support Qualitative Differences as Drivers of Disease Severity.

Authors:  Alba Grifoni; Hannah Voic; Esther Dawen Yu; Jose Mateus; Kai Mei Yan Fung; Alice Wang; Grégory Seumois; Aruna D De Silva; Rashika Tennekon; Sunil Premawansa; Gayani Premawansa; Rashmi Tippalagama; Ananda Wijewickrama; Ashu Chawla; Jason Greenbaum; Bjoern Peters; Vijayanand Pandurangan; Daniela Weiskopf; Alessandro Sette
Journal:  Vaccines (Basel)       Date:  2022-04-14

Review 4.  Sertoli Cell Immune Regulation: A Double-Edged Sword.

Authors:  Rachel L Washburn; Taylor Hibler; Gurvinder Kaur; Jannette M Dufour
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

5.  Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction.

Authors:  Brendan Zangari; Takemasa Tsuji; Junko Matsuzaki; Hemn Mohammadpour; Cheryl Eppolito; Sebastiano Battaglia; Fumito Ito; Thinle Chodon; Richard Koya; A J Robert McGray; Kunle Odunsi
Journal:  Cancer Immunol Immunother       Date:  2022-04-23       Impact factor: 6.630

6.  A pro-survival role for the intracellular granzyme B inhibitor Serpinb9 in natural killer cells during poxvirus infection.

Authors:  Matthew S Mangan; Carolina R Melo-Silva; Jennii Luu; Catherina H Bird; Aulikki Koskinen; Alexandra Rizzitelli; Monica Prakash; Katrina L Scarff; Arno Müllbacher; Matthias Regner; Phillip I Bird
Journal:  Immunol Cell Biol       Date:  2017-08-15       Impact factor: 5.126

7.  SERPINB12 Is a Slow-Binding Inhibitor of Granzyme A and Hepsin.

Authors:  Jason Z Niehaus; Mark T Miedel; Misty Good; Allyson N Wyatt; Stephen C Pak; Gary A Silverman; Cliff J Luke
Journal:  Biochemistry       Date:  2015-11-05       Impact factor: 3.162

8.  SerpinB1 controls encephalitogenic T helper cells in neuroinflammation.

Authors:  Lifei Hou; Deepak A Rao; Koichi Yuki; Jessica Cooley; Lauren A Henderson; A Helena Jonsson; Dion Kaiserman; Mark P Gorman; Peter A Nigrovic; Phillip I Bird; Burkhard Becher; Eileen Remold-O'Donnell
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

9.  A Novel Serpin Regulatory Mechanism: SerpinB9 IS REVERSIBLY INHIBITED BY VICINAL DISULFIDE BOND FORMATION IN THE REACTIVE CENTER LOOP.

Authors:  Matthew S J Mangan; Catherina H Bird; Dion Kaiserman; Anthony Y Matthews; Corinne Hitchen; David L Steer; Philip E Thompson; Phillip I Bird
Journal:  J Biol Chem       Date:  2015-12-15       Impact factor: 5.157

Review 10.  Human Granzyme B Based Targeted Cytolytic Fusion Proteins.

Authors:  Precious Hlongwane; Neelakshi Mungra; Suresh Madheswaran; Olusiji A Akinrinmade; Shivan Chetty; Stefan Barth
Journal:  Biomedicines       Date:  2018-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.